Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Bicycle Therapeutics to Participate in Upcoming Investor Conferences


Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in March:

Live webcasts of the fireside chats will be accessible in the Investor section of the company's website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available following the fireside chat dates.

About Bicycle Therapeutics

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development. The company is evaluating BT8009, a Bicycle® Toxin Conjugate (BTC®) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC targeting EphA2, a historically undruggable target; and BT7480, a Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) targeting Nectin-4 and agonizing CD137, in company-sponsored clinical trials. Additionally, the company is developing Bicycle® Radio Conjugates (BRCtm) for radiopharmaceutical use and, through various partnerships, is exploring the use of Bicycle® technology to develop therapies for diseases beyond oncology.

Bicycle Therapeutics is headquartered in Cambridge, UK, with many key functions and members of its leadership team located in Cambridge, Mass. For more information, visit bicycletherapeutics.com.


These press releases may also interest you

at 13:15
Backpack Healthcare (formerly Youme Healthcare), an online pediatric mental healthcare provider, announced today that it has raised a $14 million Series A funding round led by PACE Healthcare Capital with participation from ECMC, Techstars, Collab...

at 13:05
John Rich, a multi-platinum hit generator and music industry leader with a robust entrepreneurial and leadership resume will bring his passion and business acumen to Base Molecular Resonancetm Technologies, LLC (BMRT) as a shareholder and Strategic...

at 13:00
University Lab Partners (ULP), a premier nonprofit wet lab incubator located in Orange County, CA, has been chosen to lead the diagnostics and medical devices hub in the next generation of the BARDA Accelerator Network of the Biomedical Advanced...

at 13:00
Meet your daily step goals while supporting the region's military community at the second annual Run, Walk & Roll 5K on May 18 at Inland Empire Health Plan (IEHP)....

at 12:55
On Lok will host its annual On Lok Celebrates Friday, May 17th at Pier 27 in San Francisco. This year's theme, "The Blueprint of Senior Care," will honor On Lok's legacy of empowering Bay Area seniors to age at home with dignity and independence,...

at 12:53
CLn Skin Care, the innovative brand known for its breakthrough line of gentle yet effective cleansers for the face and body, today announces the appointment of two distinguished physician leaders to its esteemed medical advisory board (MAB) of the...



News published on and distributed by: